Skip to main content
Contact Us

Talk to our experts about how we can help your business.

Grace Webinar - Enhancing Stability and Bioavailability of Poorly Soluble APIs

Co-presented with Chemical & Engineering News (C&EN), watch the full webinar on improving pharmaceutical APIs
Image of Media Callout

Discover how silica drug delivery technology is improving the physical and chemical stability in pharmaceutical APIs.

Imagine what you could do if working with poorly soluble (BCS2) compounds was not an insurmountable issue?  BCS2 compounds account for 40% of the APIs on the market today, however, 70-80% of pharmaceuticals active in the pipeline have been shelved due to solubility issues.

Hosted by C&EN’s technical contributing editor, Jeff Huber, and presented by Grace’s technical expert, Chintan Shah, this 60-minute discussion centers on a new drug delivery option that improves physical and chemical stability in pharmaceutical APIs. 

In the webinar, you'll learn more about:

  • Ways silica drug delivery technology is giving pharmaceutical manufacturers a new solid drug dispersion option 
  • Improving solubility and bioavailability by improving the physical and chemical stability in pharmaceutical APIs 
  • Identifying ways to improve stability of poorly soluble APIs

Join our newsletter program.

Subscribe to receive the latest news and insights.

Want to talk to an expert?

Product and service inquiries

For all Grace product and service inquiries including:

  • Adsorbents
  • Catalysts and Additives
  • Fine Chemicals/Custom Manufacturing
  • Silicas
  • UNIPOL® PP Licensing
  • Safety Data Sheet
 

Non-product related inquiries

For all non-product related inquiries including:

  • Careers
  • Community and Social Responsibility
  • Corporate Communications
  • Media Relations
  • Environment, Health, and Safety (EHS)
  • Vendor and Supplier Submissions